IBO vs GILD: Which Stock is Better?

Side-by-side comparison of Impact Biomedical Inc and Gilead Sciences Inc in 2026

Comparison Updated:

IBO

Impact Biomedical Inc

$0.65

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricIBOGILDWinner
Market Cap$69.54M$170.84BGILD
P/E RatioN/A20.27GILD
EPS (TTM)$N/A$6.79GILD
Revenue Growth0.0%0.0%GILD
Gross Margin-1225.0%78.8%GILD

Analyze IBO

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IBO or GILD a better investment?

Comparing IBO and GILD: Impact Biomedical Inc has a market cap of $69.54M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IBO and GILD?

IBO (Impact Biomedical Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IBO or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IBO or GILD?

GILD has higher revenue growth at 0.0% vs 0.0% for IBO.

Which company is more profitable: IBO or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -1225.0% for IBO.

Which is the larger company: IBO or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $69.54M for IBO.

Should I buy IBO or GILD in 2026?

Both IBO and GILD have investment merit. IBO trades at $0.65 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IBO and GILD stock?

Key differences: Market Cap ($69.54M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (-1225.0% vs 78.8%).

Popular Stock Comparisons